Form D · Biotechnology
Cognos Therapeutics Inc
Inglewood, CA · CIK 0001651490
Offering snapshot reported Jul 2, 2026 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2026 | Initial | $250,000 | No comparison | 0 | SEC filing |
| Mar 31, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 12, 2021 | Initial | $55,250 | No comparison | 3 | SEC filing |
| Jul 16, 2021 | Initial | $600,015 | No comparison | Not reported | SEC filing |
| May 21, 2021 | Amendment | $3,816,795 | No comparison | Not reported | SEC filing |
| Dec 29, 2020 | Initial | $1,000,025 | No comparison | 1 | SEC filing |
| May 29, 2018 | Initial | $66,878 | No comparison | 4 | SEC filing |
| Feb 15, 2018 | Initial | $49,997 | No comparison | 1 | SEC filing |
| Apr 20, 2016 | Initial | $48,000 | No comparison | 2 | SEC filing |
| Dec 10, 2015 | Amendment | $160,000 | No comparison | 5 | SEC filing |
| Aug 24, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589537
Source: Form D, filed Jul 2, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Adell | Director, Executive |
| Frank (Aka Farokh) Adell (Aka Adelzadeh) | Director, Executive |
| Thomas Chen | Director |
| Eli Gang | Director |
| Roger Kornberg | Director |
| Roger Kornberg, Ph.D. | Director |
| Richard Lerner | Director |
| Joseph Peter | Executive |
| John Peterson | Director, Executive |
| Josh Shachar | Director |
| Ronald Solar | Director |
| Winston Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10604 S. La Cienega Blvd.
Inglewood, CA, 90304
Phone: (310) 641-2700
Inglewood, CA, 90304
Phone: (310) 641-2700